Overview

Study in Elderly Alzheimer's Patients to Assess Skin Tolerability, Irritation With 3, 7-Day Applications of DTP-System

Status:
Completed
Trial end date:
2009-06-01
Target enrollment:
Participant gender:
Summary
This study is designed to assess skin tolerability, skin irritation, and adhesion of the 350 mg Donepezil Transdermal Patch (DTP-system), following 3, 7-day applications to 3 specific areas of the body (upper back, upper middle arm, side of torso) of elderly Alzheimer's patients. The total application time for the DTP-system is 21 days.
Phase:
Phase 2
Details
Lead Sponsor:
Teikoku Pharma USA
Teikoku Pharma USA, Inc.
Treatments:
Donepezil